Matches in SemOpenAlex for { <https://semopenalex.org/work/W2606688972> ?p ?o ?g. }
- W2606688972 endingPage "1541" @default.
- W2606688972 startingPage "1534" @default.
- W2606688972 abstract "Abstract Aims Restoration of sarco/endoplasmic reticulum Ca 2+ ATPase ( SERCA2a ) activity through gene transfer improved cardiac function in experimental and pilot studies in humans with heart failure. The AGENT‐HF ( NCT01966887 ) trial investigated the impact of adeno‐associated virus ( AAV1 )/ SERCA2a on ventricular remodelling using multimodality non‐invasive cardiac imaging. Methods and results AGENT‐HF was a single centre, randomized, double‐blind, placebo‐controlled trial in adult patients with NYHA class III–IV ischaemic or non‐ischaemic heart failure and left ventricular ejection fraction ≤35%. Eligible patients were randomized to receive a single intracoronary infusion of either 1 × 10 13 DNase ‐resistant particles of AAV1 / SERCA2a or placebo. The primary endpoint was change in left ventricular end‐systolic volume ( LVESV ), measured by cardiac computed tomography at 6 month follow‐up. We planned to include 40 patients but the trial was terminated prematurely as the sponsor suspended further enrolment following neutral results of the CUPID ‐2 outcome trial. At the time of termination, nine patients were randomized with five patients infused with AAV1 / SERCA2a and four with placebo. At 6 months, LVESV was increased in both groups compared with baseline: median (interquartile range) in AAV1 / SERCA2a vs. placebo: 13 (13;14) mL vs. 3.5 (−36;36) mL , P = 0.74, with a mean difference between groups of 11.4 mL in favour of placebo. No safety issues were noted. Conclusion AGENT‐HF failed to demonstrate any improvement in ventricular remodelling in response to AAV1 / SERCA2a at the dose studied. However, because of premature termination, the study was underpowered to demonstrate an effect of AAV1 / SERCA2a and these data should be interpreted with caution." @default.
- W2606688972 created "2017-04-28" @default.
- W2606688972 creator A5003159972 @default.
- W2606688972 creator A5004368080 @default.
- W2606688972 creator A5004430363 @default.
- W2606688972 creator A5012557260 @default.
- W2606688972 creator A5019592213 @default.
- W2606688972 creator A5023368622 @default.
- W2606688972 creator A5023544315 @default.
- W2606688972 creator A5023958034 @default.
- W2606688972 creator A5025440991 @default.
- W2606688972 creator A5027244910 @default.
- W2606688972 creator A5031426939 @default.
- W2606688972 creator A5032209826 @default.
- W2606688972 creator A5044456322 @default.
- W2606688972 creator A5050887342 @default.
- W2606688972 creator A5055175064 @default.
- W2606688972 creator A5061992582 @default.
- W2606688972 creator A5062125057 @default.
- W2606688972 creator A5075841747 @default.
- W2606688972 creator A5077621721 @default.
- W2606688972 creator A5078442301 @default.
- W2606688972 creator A5086895898 @default.
- W2606688972 creator A5088096181 @default.
- W2606688972 date "2017-04-10" @default.
- W2606688972 modified "2023-10-17" @default.
- W2606688972 title "Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial" @default.
- W2606688972 cites W2001709762 @default.
- W2606688972 cites W2020569580 @default.
- W2606688972 cites W2067727865 @default.
- W2606688972 cites W2079697827 @default.
- W2606688972 cites W2081005181 @default.
- W2606688972 cites W2082748796 @default.
- W2606688972 cites W2107590406 @default.
- W2606688972 cites W2108297050 @default.
- W2606688972 cites W2123490348 @default.
- W2606688972 cites W2140141706 @default.
- W2606688972 cites W2159453909 @default.
- W2606688972 cites W2164545730 @default.
- W2606688972 cites W2220787769 @default.
- W2606688972 cites W2271175958 @default.
- W2606688972 cites W2290678689 @default.
- W2606688972 cites W2318860210 @default.
- W2606688972 cites W2620919080 @default.
- W2606688972 cites W4249896096 @default.
- W2606688972 doi "https://doi.org/10.1002/ejhf.826" @default.
- W2606688972 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28393439" @default.
- W2606688972 hasPublicationYear "2017" @default.
- W2606688972 type Work @default.
- W2606688972 sameAs 2606688972 @default.
- W2606688972 citedByCount "70" @default.
- W2606688972 countsByYear W26066889722017 @default.
- W2606688972 countsByYear W26066889722018 @default.
- W2606688972 countsByYear W26066889722019 @default.
- W2606688972 countsByYear W26066889722020 @default.
- W2606688972 countsByYear W26066889722021 @default.
- W2606688972 countsByYear W26066889722022 @default.
- W2606688972 countsByYear W26066889722023 @default.
- W2606688972 crossrefType "journal-article" @default.
- W2606688972 hasAuthorship W2606688972A5003159972 @default.
- W2606688972 hasAuthorship W2606688972A5004368080 @default.
- W2606688972 hasAuthorship W2606688972A5004430363 @default.
- W2606688972 hasAuthorship W2606688972A5012557260 @default.
- W2606688972 hasAuthorship W2606688972A5019592213 @default.
- W2606688972 hasAuthorship W2606688972A5023368622 @default.
- W2606688972 hasAuthorship W2606688972A5023544315 @default.
- W2606688972 hasAuthorship W2606688972A5023958034 @default.
- W2606688972 hasAuthorship W2606688972A5025440991 @default.
- W2606688972 hasAuthorship W2606688972A5027244910 @default.
- W2606688972 hasAuthorship W2606688972A5031426939 @default.
- W2606688972 hasAuthorship W2606688972A5032209826 @default.
- W2606688972 hasAuthorship W2606688972A5044456322 @default.
- W2606688972 hasAuthorship W2606688972A5050887342 @default.
- W2606688972 hasAuthorship W2606688972A5055175064 @default.
- W2606688972 hasAuthorship W2606688972A5061992582 @default.
- W2606688972 hasAuthorship W2606688972A5062125057 @default.
- W2606688972 hasAuthorship W2606688972A5075841747 @default.
- W2606688972 hasAuthorship W2606688972A5077621721 @default.
- W2606688972 hasAuthorship W2606688972A5078442301 @default.
- W2606688972 hasAuthorship W2606688972A5086895898 @default.
- W2606688972 hasAuthorship W2606688972A5088096181 @default.
- W2606688972 hasBestOaLocation W26066889721 @default.
- W2606688972 hasConcept C119060515 @default.
- W2606688972 hasConcept C126322002 @default.
- W2606688972 hasConcept C142724271 @default.
- W2606688972 hasConcept C164705383 @default.
- W2606688972 hasConcept C168563851 @default.
- W2606688972 hasConcept C202061045 @default.
- W2606688972 hasConcept C203092338 @default.
- W2606688972 hasConcept C204787440 @default.
- W2606688972 hasConcept C27081682 @default.
- W2606688972 hasConcept C2777707475 @default.
- W2606688972 hasConcept C2778198053 @default.
- W2606688972 hasConcept C2991744798 @default.
- W2606688972 hasConcept C71924100 @default.
- W2606688972 hasConcept C78085059 @default.
- W2606688972 hasConcept C80461066 @default.
- W2606688972 hasConceptScore W2606688972C119060515 @default.